Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Programmable Food-Derived Peptide Coassembly Strategies for Boosting Targeted Colitis Therapy by Enhancing Oral Bioavailability and Restoring Gut Microenvironment Homeostasis
2025 Standout
Works of Jean‐Philippe Guégan being referenced
Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
2022
REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort.
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jean‐Philippe Guégan | 378 | 309 | 105 | 251 | 38 | 774 | |
| Yunuo Zhao | 356 | 219 | 154 | 206 | 38 | 792 | |
| Xianglin Yuan | 265 | 271 | 115 | 115 | 31 | 656 | |
| Zhenbin Shen | 408 | 352 | 243 | 331 | 36 | 881 | |
| Li Yan | 328 | 387 | 173 | 79 | 51 | 842 | |
| Hiroyuki Eda | 342 | 403 | 61 | 193 | 37 | 983 | |
| Yijun Wang | 211 | 473 | 122 | 174 | 32 | 826 | |
| Haizeng Zhang | 254 | 304 | 121 | 93 | 39 | 708 | |
| Chunjing Wu | 307 | 531 | 141 | 144 | 37 | 984 | |
| Beatriz Arteta | 277 | 471 | 63 | 253 | 34 | 923 | |
| Kun Xie | 227 | 312 | 65 | 140 | 37 | 737 |
All Works
Login with ORCID to disown or claim papers
Loading papers...